Nuvision

Developer of an ophthalmic therapies for ocular surface disease

placeNottingham, England, United Kingdom calendar_todayFounded 2015 groups14 employees language nu-vision.co.uk

Registered entities

Social engagement

Social engagement: 2.3K social following, 5 posts in the last 12 months — below the industry typical range.

Investor mix

37 investors on record; lead investors include Mercia, Nottingham Technology Ventures, BioCity, The University of Nottingham; 1 has since exited.

Investor typeCountShare
Venture capital38%
Private equity13%
Accelerator & incubator13%
Other / undisclosed3286%

Recent activity

27 May 2026
Leadership hire
CEO
12 May 2026
Leadership hire
Non-Executive Director
31 Mar 2026
Event
Niederlande Ophthalmological Society (NOG) congress
Coming soon